If you're potentially eligible you can:

Welcome to The QUEST Initiative

The QUality of life Evaluation STudy (QUEST Initiative), conducted by researchers at the University of Sydney, aims to be the world’s largest longitudinal clinical study investigating the quality of life and health economic impact of medicinal cannabis on patients with chronic disease.

Recruitment for the QUEST Initiative has now closed. The results from the study will be posted in 2023.

If you are interested in accessing medical cannabis you should first check your eligibility for medicinal cannabis by completing this survey: Am I Eligible

Why go on this QUEST?

To understand if a ‘new’ medical treatment really works, or if it offers good value for money, we need to be able to measure a person’s health and their response to a treatment. While length of life is easy to measure, quality of life is more subjective, but we can measure it by asking patients questions about different aspects of their health such as their mobility, functionality, pain or discomfort, anxiety and depression. The QUEST Initiative will measure these and other factors through online questionnaires.

The de-identified results from this study will help future patients with certain diagnosed conditions to make better informed decisions about their treatment and understand the potential impact of cannabinoid therapy on their overall quality of life.

Contact the QUEST Support team

au-logo
Phone 1300 664 369

Please note QUEST support business hours are 9am – 5pm Australian Western Standard Time